{"id":"51f6abf2-c834-5c34-806d-b7d7da5ff60c","stable_key":"09b23d0d-35e2-51ff-b1aa-b4f9227e4fa2:isoleucine-restriction-mtor-boundary","predicate":"improves_despite","statement":"Low isoleucine improved glucose tolerance and body composition despite liver-specific Tsc1 deletion and constitutive hepatic mTORC1 activity.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"ab2e1200-476c-5bfe-a9ef-db0e0b461737","mechanism_event_label":"Suppressing liver mTORC1 was not necessary for these outcomes.","subject":{"id":"59da00d5-9277-5068-9c49-775200ebb582","slug":"mouse-low-isoleucine-diet","display_name":"Experimentally reduced-isoleucine mouse diet","entity_type_key":"cellular_process"},"object":{"id":"6b53cbae-f82b-5a58-85b6-0c698de249ae","slug":"mouse-hepatic-constitutive-mtorc1","display_name":"Constitutive hepatic mTORC1 activity in Tsc1-knockout mice","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"ab2e1200-476c-5bfe-a9ef-db0e0b461737","stable_key":"09b23d0d-35e2-51ff-b1aa-b4f9227e4fa2:isoleucine-restriction-mtor-boundary-event","event_type":"observed_relationship","label":"Suppressing liver mTORC1 was not necessary for these outcomes.","description":"Low isoleucine improved glucose tolerance and body composition despite liver-specific Tsc1 deletion and constitutive hepatic mTORC1 activity.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"59da00d5-9277-5068-9c49-775200ebb582","slug":"mouse-low-isoleucine-diet","display_name":"Experimentally reduced-isoleucine mouse diet","entity_type_key":"cellular_process"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"6b53cbae-f82b-5a58-85b6-0c698de249ae","slug":"mouse-hepatic-constitutive-mtorc1","display_name":"Constitutive hepatic mTORC1 activity in Tsc1-knockout mice","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"c85b327e-f132-5d9a-8e4b-c2976fcc0373","slug":"isoleucine","display_name":"L-Isoleucine","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"9f025af3-f039-517f-908b-4af6fc65415e","slug":"mtorc1","display_name":"Mechanistic target of rapamycin complex 1","entity_type_key":"protein_complex"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_access","value_text":"Primary full text","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Mouse liver-specific Tsc1 knockout and littermate dietary experiments.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Does not exclude mTOR roles in other organs or settings.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"L-Isoleucine collection; species, compartment, exposure, co-substrates and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"isoleucine","display_name":"L-Isoleucine","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"Suppressing liver mTORC1 was not necessary for these outcomes.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33887198/ · DOI 10.1016/j.cmet.2021.03.025","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"51415854-c8d3-5ed8-9abe-f6cc45cdc0d0","evidence_kind":"source_excerpt","locator":"Lines 394-400","start_line":394,"end_line":400,"excerpt":"## isoleucine-restriction-mtor-boundary\nSuppressing liver mTORC1 was not necessary for these outcomes.\nLow isoleucine improved glucose tolerance and body composition despite liver-specific Tsc1 deletion and constitutive hepatic mTORC1 activity.\nModel: Mouse liver-specific Tsc1 knockout and littermate dietary experiments.\nLimitations: Does not exclude mTOR roles in other organs or settings.\nEvidence access: Primary full text\nThe adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33887198/ · DOI 10.1016/j.cmet.2021.03.025","model_system":"Mouse liver-specific Tsc1 knockout and littermate dietary experiments.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"4b00f118-00fd-5cef-be97-13125eb958e9","stable_key":"import-09b23d0d-35e2-51ff-b1aa-b4f9227e4fa2","title":"L-Isoleucine: transport, translation, catabolism and cross-nutrient mechanisms (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"2058ff0da379586994e7fda6ae0086c60fa3173542bfaf1fb3871ad3e09f9c6c","revision_id":"f32192d4-9913-5d35-acbc-cf90ff17995e","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}